ArticleMolecular and cellular biochemistry2020

New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin.

Cristina Alexandra Ciocan-Cȃrtiţă et al.PubMed ↗Publisher ↗

No numbers read from the abstract.